Suchergebnisse - "Wang, Youchun"

PubPharm (20)

1

Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization

enthalten in: Journal of proteome research | 2024

von Zhang, R. | Huang, L. | Zhang, X. | +9

2

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

enthalten in: Nature | 2023

von Cao, Y. | Jian, F. | Wang, J. | +23

3

High-throughput saturation mutagenesis generates a high-affinity antibody against SARS-CoV-2 variants using protein surface display assay on a human cell

enthalten in: PLoS pathogens | 2023

von Yang, Y. | Liu, S. | Luo, Y. | +7

4

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses

enthalten in: Signal transduction and targeted therapy | 2022

von Li, Q. | Zhang, L. | Liang, Z. | +13

5

Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift

enthalten in: Journal of medical virology | 2022

von Li, T. | Cui, Z. | Jia, Y. | +17

6

A high-throughput single cell-based antibody discovery approach against the full-length SARS-CoV-2 spike protein suggests a lack of neutralizing antibodies targeting the highly conserved S2 domain

enthalten in: Briefings in bioinformatics | 2022

von Chai, M. | Guo, Y. | Yang, L. | +8

7

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

enthalten in: Cell research | 2022

von Liu, Z. | Zhou, J. | Xu, W. | +19

CommentIn: Cell Res. 2022 Apr;32(4):331-332. - PMID 35260791

8

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

enthalten in: Nature | 2022

von Cao, Y. | Wang, J. | Jian, F. | +27

CommentIn: Nat Rev Immunol. 2022 Feb;22(2):75. - PMID 35017722

9

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain

enthalten in: Signal transduction and targeted therapy | 2022

von Wu, J. | Nie, J. | Zhang, L. | +16

10

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants

enthalten in: Cell research | 2021

von Du, S. | Liu, P. | Zhang, Z. | +7